Clinical trial
A Small Prospective Clinical Study on Azvudine Tablets for Treating Chronic Hepatitis B.
NCT07307586 is registered in ClinicalTrials.gov with Zhigang Ren as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Small Prospective Clinical Study on Azvudine Tablets for Treating Chronic Hepatitis B.
- Lead sponsor
- Zhigang Ren
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 1, 2025
- Completion date
- December 31, 2027
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
azvudine, chronic hepatitis b